166 related articles for article (PubMed ID: 8780530)
1. Interferon adjuvant therapy of melanoma.
Nathanson L
Cancer; 1996 Sep; 78(5):944-7. PubMed ID: 8780530
[No Abstract] [Full Text] [Related]
2. Cutaneous melanoma metastases.
Lee JE; Mansfield PF; Ross MI
N Engl J Med; 1998 Mar; 338(13):922-3. PubMed ID: 9518292
[No Abstract] [Full Text] [Related]
3. Systemic therapy for cutaneous melanoma.
Treisman J; Garlie N
Clin Plast Surg; 2010 Jan; 37(1):127-46. PubMed ID: 19914464
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials referral resource. Melanoma.
Cheson BD
Oncology (Williston Park); 1991 Jun; 5(6):95, 98, 101. PubMed ID: 1831644
[No Abstract] [Full Text] [Related]
5. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
6. Adjuvant interferon in melanoma.
Retsas S
Lancet; 1994 Jun; 343(8911):1498-9. PubMed ID: 7515454
[No Abstract] [Full Text] [Related]
7. Adjuvant therapy of melanoma.
Spitler LE
Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):40-8. PubMed ID: 11829281
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for cutaneous malignant melanoma.
Demierre MF; Koh HK
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):747-64. PubMed ID: 9146538
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant application of interferons.
el Kassas H; Kirkwood JM
Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
[No Abstract] [Full Text] [Related]
10. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
11. [Adjuvant interferon therapy in malignant melanoma].
Mohr P
J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
[No Abstract] [Full Text] [Related]
12. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
13. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
14. [Melanoma: current controversies and future perspectives].
Dorval T
Bull Cancer; 1998 Feb; 85(2):187-90. PubMed ID: 9752338
[No Abstract] [Full Text] [Related]
15. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
[TBL] [Abstract][Full Text] [Related]
16. Treating patients with melanoma with interferon.
Cook J; Zitelli JA
Arch Dermatol; 1997 Mar; 133(3):387-9. PubMed ID: 9080905
[No Abstract] [Full Text] [Related]
17. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
Jack A; Boyes C; Aydin N; Alam K; Wallack M
Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
[TBL] [Abstract][Full Text] [Related]
18. New therapies for malignant melanoma.
Hancock B
Practitioner; 1989 Oct; 233(1477):1385-6, 1388. PubMed ID: 2482487
[TBL] [Abstract][Full Text] [Related]
19. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
20. [Melanoma].
Saida T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
